Gavan Technologies, a food technology start-up, has secured $8m in A-round funds to commercialise its advanced protein-based fat solution, Fatrix.

This investment will help Gavan Technologies enter the European food market.

The funding round was led by MoreVC, an Israeli venture capital firm. Lever VC, a global food and agri-tech investor, also participated.

EIT Food, a European Union (EU)-backed platform for sustainable food innovations, joined the round. DarkBoot Group, a private equity firm involved in Gavan Technologies’ incubation, also contributed to the funding.

The functional ingredients developer previously raised $2.5m in seed funds.

The latest proceeds will fund the establishment of a new pilot production facility in Europe, focused on expanding its presence in the bakery and dairy sectors.

Set to begin operations in April 2025, the facility will feature an advanced production line for Gavan Technologies’ alternative fat solution.

Gavan Technologies co-founder and CEO Itai Cohen said: “This funding round opens the door for Gavan to enter the European food market, where we can quickly make a positive impact.

“Our new, fully EU-certified facility is planned to go commercial as early as April next year.”

Fatrix is designed to help food manufacturers achieve a superior Nutri-Score by reducing total and saturated fat content.

As a fat source, the solution decreases reliance on animal fats, provides sensory value, and enables cleaner labels by eliminating unwanted emulsifiers.

Fatrix is a versatile, plant-based fat developed by Gavan Technologies’ foodtech experts. It can replace butter on a one-to-one basis in a wide variety of bakery products and dairy alternatives.

The all-natural formula consists of three simple ingredients, protein isolate, vegetable oil, and water, combined into a high-performance gel.

Using Gavan Technologies’ patented technology, the protein acts as an ideal binder for water and oil, creating a smooth, stable, and flavourless emulsion.

With very low saturated fats and zero trans fats, Fatrix is not hydrogenated. It is already approved for market and does not require novel food regulatory approval.

Gavan Technologies said that Fatrix fills the market gap for a clean-label fat substitute that is both functional and cost-effective.

Lever VC partner James Caffyn said: “Gavan’s platform stands out as the most compelling, offering a unique ability to partner with large corporates while achieving capital-efficient scaling and competitive unit economics.

“These qualities position Fatrix as a game-changer in the move towards healthier and cleaner-label foods.”